Ignite Creation Date:
2025-12-24 @ 5:16 PM
Ignite Modification Date:
2026-01-27 @ 8:58 AM
Study NCT ID:
NCT05385250
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-08-15
First Post:
2022-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II
Sponsor:
Karen-Lise Garm Spindler
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
DACG-II
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None